BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9637273)

  • 21. Syndrome of myelofibrosis and osteosclerosis: a series of case reports and review of the literature.
    Diamond T; Smith A; Schnier R; Manoharan A
    Bone; 2002 Mar; 30(3):498-501. PubMed ID: 11882464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow lymphoid nodules in myeloproliferative disorders: association with the nonmyelosclerotic phases of idiopathic myelofibrosis and immunological significance.
    Cervantes F; Pereira A; Marti JM; Feliu E; Rozman C
    Br J Haematol; 1988 Nov; 70(3):279-82. PubMed ID: 3207625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological studies on the bone tissue of sternum in osteomyelosclerosis, panmyelosis and chronic myeloleukosis.
    Velizarov A; Valkov I
    Nauchni Tr Vissh Med Inst Sofiia; 1970; 49(3):61-71. PubMed ID: 4253273
    [No Abstract]   [Full Text] [Related]  

  • 24. Agnogenic myeloid metaplasia (AMM)--correlation of bone marrow lesions with laboratory data: a longitudinal clinicopathological study on 114 patients.
    Thiele J; Zankovich R; Steinberg T; Fischer R; Diehl V
    Hematol Oncol; 1989; 7(5):327-43. PubMed ID: 2767619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and quantification of bone marrow fibrosis are significantly biased by the pre-staining processing of bone marrow biopsies.
    Buesche G; Georgii A; Kreipe HH
    Histopathology; 2006 Jan; 48(2):133-48. PubMed ID: 16405662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Regressive bone marrow changes in leukoses with special reference to their demarcation from myelofibrosis and osteomyelosclerosis].
    Martin H
    Zentralbl Allg Pathol; 1969; 112(3):310-20. PubMed ID: 4900564
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversal of myelofibrosis by hydroxyurea.
    Löfvenberg E; Wahlin A; Roos G; Ost A
    Eur J Haematol; 1990 Jan; 44(1):33-8. PubMed ID: 2307218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Jamshidi biopsy in clinical hematology. Method, indications and results of over 1,000 completed biopsies with special reference to chronic myeloproliferative diseases].
    Seewann HL
    Wien Med Wochenschr Suppl; 1986; 100():1-24. PubMed ID: 3471009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of fibrosis and osteosclerosis in myeloproliferative neoplasms: a computer-assisted image study.
    Teman CJ; Wilson AR; Perkins SL; Hickman K; Prchal JT; Salama ME
    Leuk Res; 2010 Jul; 34(7):871-6. PubMed ID: 20122729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification.
    Buhr T; Georgii A; Choritz H
    Pathol Res Pract; 1993 Mar; 189(2):121-32. PubMed ID: 8321741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelofibrosis in Patients of Chronic Myeloid Leukemia in Chronic Phase at Presentation.
    Hamid A; Ashraf S; Qamar S; Naveed MA; Hameed A; Farooq MA
    J Coll Physicians Surg Pak; 2019 Nov; 29(11):1096-1100. PubMed ID: 31659970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of bone marrow fibrosis and subsequent development of polycythemia in patients with myeloproliferative disorders.
    Talarico L; Wolf BC; Kumar A; Weintraub LR
    Am J Hematol; 1989 Apr; 30(4):248-53. PubMed ID: 2929585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis of chronic myeloproliferative diseases based on bone marrow biopsy].
    Matolcsy A; Kónya T; Wéber E
    Orv Hetil; 1992 Jun; 133(26):1617-20, 1625-6. PubMed ID: 1614699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone changes in myelofibrosis with myeloid metaplasia: a histomorphometric and microcomputed tomographic study.
    Schmidt A; Blanchet O; Dib M; Baslé MF; Ifrah N; Chappard D
    Eur J Haematol; 2007 Jun; 78(6):500-9. PubMed ID: 17419743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating haemopoietic progenitor cells in primary and secondary myelofibrosis: relation to collagen and reticulin fibrosis.
    Colović MD; Wiernik PH; Janković GM; Vidović AD; Janosević S; Basara NM
    Eur J Haematol; 1999 Mar; 62(3):155-9. PubMed ID: 10089892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD).
    Bartl R; Frisch B; Wilmanns W
    Eur J Haematol; 1993 Jan; 50(1):41-52. PubMed ID: 8436214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients.
    Thiele J; Simon KG; Fischer R; Zankovich R
    Pathol Res Pract; 1988 Aug; 183(4):434-45. PubMed ID: 3186544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A cytogenetical study of chronic myeloid leukemia, osteomyelosclerosis, myelofibrosis and erythrema].
    Piatkin EK
    Tsitologiia; 1966; 8(2):229-40. PubMed ID: 5234136
    [No Abstract]   [Full Text] [Related]  

  • 40. [A case of post-essential thrombocythemia myelofibrosis with severe osteosclerosis].
    Lee KK; Cho HI; Chi HS; Kim DY; Chae SL; Huh HJ
    Korean J Lab Med; 2010 Apr; 30(2):122-5. PubMed ID: 20445328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.